Dopamine D 2/D 3 receptor availability in genetically leptin-deficient patients after long-term leptin replacement

Molecular Psychiatry

Volumn 17, Issue 4, 2012, Pages 352-353

  Ishibashi, K ^a   Berman, S M ^a,b   Paz Filho, G ^c   Lee, B ^a   Robertson, C ^a   Mandelkern, M A ^d   Wong, M L ^c   Licinio, J ^c   London, E D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Biology and Environment   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; LEPTIN; RECOMBINANT METHIONYL; SPIPERONE; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FALLYPRIDE; FLUORINE; RECOMBINANT METHIONYL HUMAN LEPTIN;

ADULT; AUTORADIOGRAPHY; BINDING AFFINITY; BODY WEIGHT; CASE REPORT; CONTROLLED STUDY; DRUG WITHDRAWAL; ENDOCRINE FUNCTION; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FEMALE; GENE; GENE MUTATION; GLOBUS PALLIDUS; GRAY MATTER; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LEPTIN DEFICIENCY; LETTER; MALE; MISSENSE MUTATION; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; PUTAMEN; TURKEY (REPUBLIC); WILD TYPE; CASE CONTROL STUDY; CORPUS STRIATUM; GENETICS; METABOLISM; METHODOLOGY; RADIOASSAY;

ADULT; BENZAMIDES; CASE-CONTROL STUDIES; CORPUS STRIATUM; FEMALE; FLUORINE RADIOISOTOPES; HORMONE REPLACEMENT THERAPY; HUMANS; LEPTIN; MALE; MUTATION, MISSENSE; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 84858998755     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.156     Document Type: Letter

References (10)

1. Opland DM, Leinninger GM, Myers Jr MG. Brain Res 2010; 1350: 65-70.
2. Pfaffly J, Michaelides M, Wang GJ, Pessin JE, Volkow ND, Thanos PK. Synapse 2010; 64: 503-510.
3. Liu J, Perez SM, Zhang W, Lodge DJ, Lu XY. Mol Psychiatry 2011; 16: 1024-1038.
4. Licinio J, Caglayan S, Ozata M, Yildiz BO, de Miranda PB, O'Kirwan F et al. Proc Natl Acad Sci USA 2004; 101: 4531-4536.
5. Matochik JA, London ED, Yildiz BO, Ozata M, Caglayan S, DePaoli AM et al. J Clin Endocrinol Metab 2005; 90: 2851-2854.
6. Baicy K, London ED, Monterosso J, Wong ML, Delibasi T, Sharma A et al. Proc Natl Acad Sci USA 2007; 104: 18276-18279.
7. London ED, Berman SM, Chakrapani S, Delibasi T, Monterosso J, Erol HK et al. J Clin Endocrinol Metab 2011; 96: E1212-E1220.
8. Berman SM, Paz-Filho G, Wong ML, Kohno M, Licinio J, London ED (submitted for publication).
9. Paz-Filho G, Wong ML, Licinio J. Obes Rev 2011; 12: e315-e323.
10. Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR et al. J Neurosci 2009; 29: 14734-14740.